Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$14.32
0.201.42%
Pre-Market: 8:19 AM EDT
Comments
Loading...
Denali Therapeutics (DNLI) Forecast
NewsEarningsDenali Therapeutics (DNLI) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Denali Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DNLI | Benzinga
Explore Denali Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DNLI.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Denali Therapeutics (DNLI) stock?
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Who are Denali Therapeutics (DNLI) competitors?
Other companies in Denali Therapeutics’s space includes: MoonLake (NASDAQ:MLTX), Centessa Pharmaceuticals (NASDAQ:CNTA), Arcutis Biotherapeutics (NASDAQ:ARQT), Mesoblast (NASDAQ:MESO) and Arrowhead Pharma (NASDAQ:ARWR).
What is the forecast, or price target, for Denali Therapeutics (DNLI) stock?
Denali Therapeutics has a consensus price target of $38.79.
What is the current price for Denali Therapeutics (DNLI)?
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $14.32 last updated March 26, 2025 at 8:19 AM EDT.
Does Denali Therapeutics (DNLI) pay a dividend?
There are no upcoming dividends for Denali Therapeutics.
When is Denali Therapeutics (NASDAQ:DNLI) reporting earnings?
Denali Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
Is Denali Therapeutics (DNLI) going to split?
There is no upcoming split for Denali Therapeutics.
What sector and industry does Denali Therapeutics (DNLI) operate in?
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.